Home | Publications | European Renal and Cardiovascular Medicine

European Renal and Cardiovascular Medicine

Discover the papers published by EuReCa-M – European Renal and Cardiovascular Medicine Working Group.

10 / 19 results found

Stratified medicine for blood pressure targets in type 2 diabetes mellitus

January 13, 2025

EuReCa-M WG

Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease

February 21, 2024

EuReCa-M WG

COVID-19 and cardiovascular disease in patients with chronic kidney disease

September 28, 2023

EuReCa-M WG

SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EuReCa-M and ERBP working groups of ERA

May 25, 2023

ERBP

EuReCa-M CME 2022

September 09, 2022

EuReCa-M WG

Sodium–glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease: a new erahas already begun

June 20, 2021

EuReCa-M WG

Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease

May 04, 2021

EuReCa-M WG

Intravenous iron therapy and the cardiovascular system: risks and benefits

November 26, 2020

Clinical Kidney Journal

Same rhythm, different song: approaches to atrial fibrillation management by cardiologists and nephrologists

September 27, 2020

Clinical Kidney Journal

Treatment of resistant hypertension in the hemodialysis population: a 44-h ambulatory BP Monitoring (ABPM) Study

September 20, 2020

EuReCa-M WG

Join the ERA Working Groups or renew your interest

Discover our Members’ stories

The first ERA Education Meeting will take place on March 27-28, 2025, in Lisbon, Portugal

Listen to our new podcast series

Discover the ERA Neph-Manual

Try the mushrooms crepes

Webcast available!

Webcast available!

Suggestions

European Renal and Cardiovascular Medicine

{%TITLE%}

{%TITLE%}

Stratified medicine for blood pressure targets in type 2 diabetes mellitus

Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease

COVID-19 and cardiovascular disease in patients with chronic kidney disease

SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EuReCa-M and ERBP working groups of ERA

EuReCa-M CME 2022

Sodium–glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease: a new erahas already begun

Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease

Intravenous iron therapy and the cardiovascular system: risks and benefits

Same rhythm, different song: approaches to atrial fibrillation management by cardiologists and nephrologists

Treatment of resistant hypertension in the hemodialysis population: a 44-h ambulatory BP Monitoring (ABPM) Study